These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2305175)

  • 21. Mitigation of in vitro hydrogen sulfide production using bismuth subsalicylate with and without monensin in beef feedlot diets.
    Ruiz-Moreno M; Binversie E; Fessenden SW; Stern MD
    J Anim Sci; 2015 Nov; 93(11):5346-54. PubMed ID: 26641054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mucin: a probable endogenous substrate of intestinal fermentation].
    Barúa RL; Tello Casanova R
    Acta Gastroenterol Latinoam; 1984; 14(4):279-83. PubMed ID: 6537703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiology of sulfide in the rat colon: use of bismuth to assess colonic sulfide production.
    Levitt MD; Springfield J; Furne J; Koenig T; Suarez FL
    J Appl Physiol (1985); 2002 Apr; 92(4):1655-60. PubMed ID: 11896034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of effects of ethyl alcohol and bismuth subsalicylate on gastric mucosal barrier in man.
    Dy RM; Lof J; DiBaise JK; Quigley EM
    Dig Dis Sci; 1999 Feb; 44(2):286-9. PubMed ID: 10063913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of an ammonia electrode for rapid quantification of Helicobacter pylori urease: its use in the endoscopy room and in the assessment of urease inhibition by bismuth subsalicylate.
    Butcher GP; Ryder SD; Hughes SJ; Stewart M; Bird N; Haqqani MT; Rhodes JM
    Digestion; 1992; 53(3-4):142-8. PubMed ID: 1291402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
    Domenico P; Landolphi DR; Cunha BA
    J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.
    Mahony DE; Woods A; Eelman MD; Burford N; Veldhuyzen van Zanten SJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):431-3. PubMed ID: 15616328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation.
    Jiang T; Savaiano DA
    J Nutr; 1997 Aug; 127(8):1489-95. PubMed ID: 9237942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.
    Kocoshis SA; Ghent CN; Gryboski JD
    Dig Dis Sci; 1984 Dec; 29(12):1148-52. PubMed ID: 6499633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding and killing of bacteria by bismuth subsalicylate.
    Sox TE; Olson CA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2075-82. PubMed ID: 2694949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of a calcium carbonate-bismuth subsalicylate combination on intragastric acidity over the course of 24 hours. A randomized study of healthy probands].
    Hopert R; Emde C; Barner M; Vallo-Wermes M; Riecken EO
    Med Klin (Munich); 1989 Mar; 84(3):135-8. PubMed ID: 2716711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of bismuth subsalicylate in relieving symptoms of indigestion.
    Hailey FJ; Newsom JH
    Arch Intern Med; 1984 Feb; 144(2):269-72. PubMed ID: 6365007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats.
    Furne JK; Suarez FL; Ewing SL; Springfield J; Levitt MD
    Dig Dis Sci; 2000 Jul; 45(7):1439-43. PubMed ID: 10961726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmucosal penetration of bismuth particles in the human stomach.
    Nwokolo CU; Lewin JF; Hudson M; Pounder RE
    Gastroenterology; 1992 Jan; 102(1):163-7. PubMed ID: 1727749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
    Graham DY; Estes MK; Gentry LO
    Gastroenterology; 1983 Nov; 85(5):1017-22. PubMed ID: 6352386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications.
    Vega-Jiménez AL; Almaguer-Flores A; Flores-Castañeda M; Camps E; Uribe-Ramírez M; Aztatzi-Aguilar OG; De Vizcaya-Ruiz A
    Nanotechnology; 2017 Oct; 28(43):435101. PubMed ID: 28837052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of feeding xanthan gum on colonic function in man: correlation with in vitro determinants of bacterial breakdown.
    Daly J; Tomlin J; Read NW
    Br J Nutr; 1993 May; 69(3):897-902. PubMed ID: 8329363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of colonic fermentation by bifidobacteria and pH in vitro. Impact on lactose metabolism, short-chain fatty acid, and lactate production.
    Jiang T; Savaiano DA
    Dig Dis Sci; 1997 Nov; 42(11):2370-7. PubMed ID: 9398819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.
    Gavey CJ; Szeto ML; Nwokolo CU; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 1989 Feb; 3(1):21-8. PubMed ID: 2491455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.